Mcrae Capital Management Inc Bristol Myers Squibb CO Transaction History

Mcrae Capital Management Inc

$419 Million
Q2 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 21, 2023	SELL	$63.71 - $70.74 $12.9 Million - $14.3 Million	-202,442 Reduced 97.61%	4,953 $316,000
Q1 2023 Apr 19, 2023	BUY	$65.71 - $74.53 $7,885 - $8,943	120 Added 0.06%	207,395 $14.4 Million
Q4 2022 Jan 20, 2023	SELL	$68.48 - $81.09 $228,380 - $270,435	-3,335 Reduced 1.58%	207,275 $0
Q3 2022 Oct 20, 2022	BUY	$0.13 - $76.84 $144 - $85,676	1,115 Added 0.53%	210,610 $15 Million
Q2 2022 Jul 20, 2022	SELL	$72.62 - $79.98 $97,456 - $107,333	-1,342 Reduced 0.64%	209,495 $16.1 Million
Q1 2022 Apr 21, 2022	SELL	$61.48 - $73.72 $63,201 - $75,784	-1,028 Reduced 0.49%	210,837 $15.4 Million
Q4 2021 Jan 26, 2022	BUY	$53.63 - $62.52 $120,667 - $140,670	2,250 Added 1.07%	211,865 $13.2 Million
Q3 2021 Oct 26, 2021	BUY	$59.17 - $69.31 $138,694 - $162,462	2,344 Added 1.13%	209,615 $12.4 Million
Q2 2021 Jul 28, 2021	BUY	$61.91 - $67.42 $198,731 - $216,418	3,210 Added 1.57%	207,271 $13.9 Million
Q1 2021 May 11, 2021	BUY	$59.34 - $66.74 $1.67 Million - $1.88 Million	28,210 Added 16.04%	204,061 $12.9 Million
Q4 2020 Jan 27, 2021	BUY	$57.74 - $65.43 $1.13 Million - $1.28 Million	19,510 Added 12.48%	175,851 $10.9 Million
Q3 2020 Nov 09, 2020	BUY	$57.43 - $63.64 $651,485 - $721,932	11,344 Added 7.82%	156,341 $9.43 Million
Q2 2020 Jul 23, 2020	BUY	$54.82 - $64.09 $243,126 - $284,239	4,435 Added 3.16%	144,997 $8.53 Million
Q1 2020 Apr 16, 2020	BUY	$46.4 - $67.43 $1 Million - $1.46 Million	21,595 Added 18.15%	140,562 $7.84 Million
Q4 2019 Jan 17, 2020	BUY	$49.21 - $64.19 $5.5 Million - $7.18 Million	111,867 Added 1575.59%	118,967 $7.64 Million
Q3 2019 Oct 21, 2019	BUY	$42.77 - $50.71 $76,986 - $91,278	1,800 Added 33.96%	7,100 $360,000
Q2 2019 Jul 29, 2019	BUY	$44.62 - $49.34 $236,486 - $261,502	5,300 New	5,300 $240,000
Q2 2018 Jul 16, 2018	SELL	$50.53 - $62.98 $164,222 - $204,685	-3,250 Closed	0 $0
Q1 2018 May 09, 2018	SELL	$59.92 - $68.98 $20,972 - $24,143	-350 Reduced 9.72%	3,250 $206,000
Q4 2017 Feb 13, 2018	BUY	$59.94 - $65.35 $17,982 - $19,605	300 Added 9.09%	3,600 $221,000
Q3 2017 Oct 23, 2017	BUY	$55.23 - $63.74 $182,259 - $210,342	3,300	3,300 $210,000

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

Vanguard Group Inc Valley Forge, PA

187M
Shares

$9.92 Billion
0.15% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$8.44 Billion
0.15% of portfolio
State Street Corp Boston, MA

91.4M
Shares

$4.86 Billion
0.17% of portfolio
Jpmorgan Chase & CO New York, NY

74.6M
Shares

$3.97 Billion
0.27% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

59.1M
Shares

$3.14 Billion
0.47% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mcrae Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mcrae Capital Management Inc with notifications on news.

Account